Abstract:Objectives/hypothesis: Patients with advanced oral cavity cancer (OCC) typically have not been enrolled in clinical trials utilizing contemporary multimodality strategies. There exist dogmatic expectations of inferior outcome in OCC patients secondary to ineffectiveness of treatment and unacceptable toxicity. The purpose of this study was to analyze survival, swallowing function, and incidence of osteoradionecrosis (ORN) of patients with stage III/IV OCC who have undergone primary concomitant chemoradiotherapy (CRT). Methods: All advanced OCC patients who were enrolled in University of Chicago concomitant CRT protocols from 1994 to 2008 were reviewed. One hundred eleven newly diagnosed advanced OCC patients were evaluated. We performed a subset analysis of 27 additional advanced OCC patients who underwent surgery followed by postoperative CRT. Swallowing function was assessed via oropharyngeal motility study, and a Swallowing Performance Status Scale score was assigned. Presence of clinically significant ORN was documented. Results: Median follow-up was 3.25 years. Five-year overall and progression-free survival was 66.9% and 65.9%, respectively. There was no difference in overall or progression-free survival when the surgery-first group was compared with the primary CRT group (P = .88 and P = .86 respectively). Function, without gastric tube requirement, was excellent, with 92.2% of patients able to maintain weight via oral route. Incidence of ORN was 18.4%, occurring in nine of 49 patients evaluated. Conclusions: Our data support the use of primary CRT as a viable treatment option for patients with advanced OCC. Survival is high, and overall function for the majority of patients is satisfactory. Patients with T4 oral tongue cancer may be spared total glossectomy. The incidence of ORN may be considered acceptable, in light of the benefits of enduring life and function.

Combined-modality treatment for advanced oral tongue squamous cell carcinoma

Clinical Effect of Postoperative Chemoradiotherapy in Resected Advanced Laryngeal Squamous Cell Carcinoma.

Influence of Pathologic Complete Response to Induction Chemotherapy onLong-Term Survival of Patients Advanced Squamous Cell Carcinoma of the OralCavity Tongue

[Treatment and Prognostic Analysis of 92 Cases with Advanced Mobile Tongue Squamous Cell Carcinoma].

[Survival analysis of 229 patients with advanced squamous cell carcinoma of the oral tongue].

Postoperative Concurrent Chemoradiation for Oral Squamous Cell Carcinoma with Multiple Minor Risk Factors

Role of Combination Chemotherapy for 118 Patients with Advanced Squamous Cell Carcinoma of Head and Neck

Postoperative radiotherapy with or without concurrent chemotherapy for oral squamous cell carcinoma in patients with three or more minor risk factors: a propensity score …

Concurrent chemoradiotherapy using cisplatin, tegafur, and leucovorin for advanced squamous cell carcinoma of the hypopharynx and oropharynx

Parameters to assess the necessity of adjuvant therapy for early-stage oral squamous cell carcinoma

Chemoradiation for patients with advanced oral cavity cancer

[Results of Stage I and II Tongue Squamous Cell Carcinomas Treated with Different Modalities].

Neoadjuvant Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma: A Single Center Study

Clinical and prognostic analysis of second primary squamous cell carcinoma of the tongue after radiotherapy for nasopharyngeal carcinoma

Survival analysis of 127 patients with tongue squamous cell carcinoma barely underwent radical surgery

Postoperative concomitant chemoradiotherapy improved treatment outcomes of patients with oral cavity cancer with multiple-node metastases but no other major risk factors

Sequential Therapy of Advanced Buccal Mucosa Squamous Cell Carcinoma: Three-Year Outcome

Comparison of treatment modalities for selected advanced laryngeal squamous cell carcinoma

Prognostic Factors of Early Tongue Squamous Cell Carcinoma and Neck Treatment

Comparative Survival Outcomes Of Different Treatments For Oral Tongue Squamous Cell Carcinoma In Elderly Patients Aged 65 Years And Older: A Propensity Score Matched Analysis

Identification of a high-risk subgroup of patients with resected pT3 oral cavity cancer in need of postoperative adjuvant therapy